Citicoline May Effectively Reduce Hard Exudates in Diabetic Retinopathy

Area of Science:

• Ophthalmology
• Neuroscience
• Pharmacology

Background:

• Diabetic retinopathy (DR) involves vascular, inflammatory, and neurodegenerative processes.
• Citicoline offers neuroprotection, reduces oxidative stress, and enhances neurotransmitter levels.
• Liposomal citicoline eye drops show potential in preventing diabetes-induced retinal neurodegeneration.

Purpose of the Study:

• To evaluate the clinical impact of citicoline eye drops on diabetic retinopathy signs.
• To assess the efficacy of citicoline in managing nonproliferative diabetic retinopathy (NPDR).

Main Methods:

• Prospective observational study of over 100 patients with NPDR.
• Color-fundus photography of macular and optic disc fields.
• Treatment with citicoline eye drops for at least one year.

Main Results:

• Reduction or complete disappearance of macular hard exudates observed in 4 patients.
• Positive clinical effects noted after 6-12 months of citicoline eye drop application.

Conclusions:

• This study suggests a potential clinical benefit of citicoline eye drops for hard exudates in DR.
• Further statistical analysis and larger prospective studies are required to confirm these findings.